Arca Biopharma | ABIO - Market Capitalization


Arca Biopharma reported $904.7M in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alterity Therapeutics Limited AUD 30M 26M Apr/2026
Amgen USD 176.25B 24.32B Dec/2025
Arca Biopharma USD 1.47B 537M Dec/2025
Biogen USD 25.82B 5.28B Dec/2025
Brainstorm Cell Therapeutics USD 8M 3M Sep/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Capricor Therapeutics USD 1.66B 1.33B Dec/2025
Cipla INR 1.22T 6.47B Dec/2025
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 144.67M 7.17M Dec/2025
CSL USD 55.89B 20.42B Dec/2025
Cytokinetics USD 7.77B 1.19B Dec/2025
Daiichi Sankyo JPY 6.34T 62.51B Dec/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Laboratory Of America USD 20.8B 3.03B Dec/2025
Myriad Genetics USD 575M 98M Dec/2025
Otsuka Holdings JPY 4.82T 550.59B Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
United Therapeutics USD 20.98B 2.02B Dec/2025